HOWL
Price
$1.60
Change
-$0.07 (-4.19%)
Updated
Oct 17 closing price
Capitalization
73.17M
18 days until earnings call
PHVS
Price
$21.12
Change
-$0.74 (-3.39%)
Updated
Oct 17 closing price
Capitalization
1.36B
17 days until earnings call
Interact to see
Advertisement

HOWL vs PHVS

Header iconHOWL vs PHVS Comparison
Open Charts HOWL vs PHVSBanner chart's image
Werewolf Therapeutics
Price$1.60
Change-$0.07 (-4.19%)
Volume$556.19K
Capitalization73.17M
Pharvaris
Price$21.12
Change-$0.74 (-3.39%)
Volume$246.62K
Capitalization1.36B
HOWL vs PHVS Comparison Chart in %
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. PHVS commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and PHVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (HOWL: $1.60 vs. PHVS: $21.12)
Brand notoriety: HOWL and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 69% vs. PHVS: 125%
Market capitalization -- HOWL: $73.17M vs. PHVS: $1.36B
HOWL [@Biotechnology] is valued at $73.17M. PHVS’s [@Biotechnology] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, HOWL is a better buy in the long-term than PHVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 5 bullish TA indicator(s).

  • HOWL’s TA Score: 5 bullish, 4 bearish.
  • PHVS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than PHVS.

Price Growth

HOWL (@Biotechnology) experienced а -1.84% price change this week, while PHVS (@Biotechnology) price change was -3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

HOWL is expected to report earnings on Nov 06, 2025.

PHVS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.36B) has a higher market cap than HOWL($73.2M). PHVS YTD gains are higher at: 10.172 vs. HOWL (8.108). HOWL has higher annual earnings (EBITDA): -66.34M vs. PHVS (-165.21M). PHVS has more cash in the bank: 200M vs. HOWL (77.6M). PHVS has less debt than HOWL: PHVS (634K) vs HOWL (37.1M). HOWL (0) and PHVS (0) have equivalent revenues.
HOWLPHVSHOWL / PHVS
Capitalization73.2M1.36B5%
EBITDA-66.34M-165.21M40%
Gain YTD8.10810.17280%
P/E RatioN/AN/A-
Revenue00-
Total Cash77.6M200M39%
Total Debt37.1M634K5,852%
TECHNICAL ANALYSIS
Technical Analysis
HOWLPHVS
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVTAX11.290.10
+0.89%
SEI Global Managed Volatility F (SIMT)
FMDRX33.770.20
+0.60%
Franklin Mutual Global Discovery R6
FCAOX13.900.04
+0.29%
Fidelity Advisor Climate Action M
WRHIX5.970.01
+0.17%
Macquarie High Income Fund Class C
MICIX10.38-0.01
-0.10%
Victory Trivalent Intl Fd-Core Eq I

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with CLDX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-4.19%
CLDX - HOWL
40%
Loosely correlated
+1.05%
BCRX - HOWL
38%
Loosely correlated
-1.34%
GNPX - HOWL
38%
Loosely correlated
-23.68%
OCUL - HOWL
37%
Loosely correlated
-2.95%
CELC - HOWL
37%
Loosely correlated
-1.09%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with NUVL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-3.39%
NUVL - PHVS
36%
Loosely correlated
+2.32%
INKT - PHVS
34%
Loosely correlated
-3.05%
SNDX - PHVS
32%
Poorly correlated
-4.98%
MGTX - PHVS
32%
Poorly correlated
-4.67%
GBIO - PHVS
31%
Poorly correlated
-6.93%
More